Chemiluminescence Brings Renaissance in TTI Screening: Primi Experientia
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Chatterjee K, Coshic P, Borgohain M, Premchand , Thapliyal R, Chakroborty S
. Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. Natl Med J India. 2013; 25(4):207-9.
View
2.
Meena M, Jindal T, Hazarika A
. Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study. Transfusion. 2010; 51(1):198-202.
DOI: 10.1111/j.1537-2995.2010.02801.x.
View
3.
Kim S, Kim J, Yoon S, Park Y, Kim H
. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol. 2008; 46(12):3919-23.
PMC: 2593301.
DOI: 10.1128/JCM.01603-08.
View
4.
Chaurasia R, Zaman S, Das B, Chatterjee K
. Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience. J Blood Transfus. 2014; 2014:412105.
PMC: 4248483.
DOI: 10.1155/2014/412105.
View
5.
Pallavi P, Ganesh C, Jayashree K, Manjunath G
. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus. 2012; 27(1):1-6.
PMC: 3102503.
DOI: 10.1007/s12288-010-0047-x.
View